Richard Kensinger - Search Results

Year	Number of Results
2002	1
2004	3
2007	1
2010	1
2021	1
2022	2
2024	0

1

Preclinical development of the quadrivalent meningococcal (ACYW) tetanus toxoid conjugate vaccine, MenQuadfi®.

Kensinger R, Arunachalam AB. Kensinger R, et al. Glycoconj J. 2022 Jun;39(3):381-392. doi: 10.1007/s10719-022-10050-2. Epub 2022 Apr 20. Glycoconj J. 2022. PMID: 35441968 Free PMC article.

2

The Highly Productive Thermothelomyces heterothallica C1 Expression System as a Host for Rapid Development of Influenza Vaccines.

Keresztes G, Baer M, Alfenito MR, Verwoerd TC, Kovalchuk A, Wiebe MG, Andersen TK, Saloheimo M, Tchelet R, Kensinger R, Grødeland G, Emalfarb M. Keresztes G, et al. Among authors: kensinger r. Vaccines (Basel). 2022 Jan 20;10(2):148. doi: 10.3390/vaccines10020148. Vaccines (Basel). 2022. PMID: 35214607 Free PMC article.

3

Predictive modeling for assessing the long-term thermal stability of a new fully-liquid quadrivalent meningococcal tetanus toxoid conjugated vaccine.

Neyra C, Clénet D, Bright M, Kensinger R, Hauser S. Neyra C, et al. Among authors: kensinger r. Int J Pharm. 2021 Nov 20;609:121143. doi: 10.1016/j.ijpharm.2021.121143. Epub 2021 Sep 29. Int J Pharm. 2021. PMID: 34600051 Free article.

4

Social work and psychotropic medication.

Kensinger RG. Kensinger RG. Soc Work. 2007 Apr;52(2):191-2. doi: 10.1093/sw/52.2.191-a. Soc Work. 2007. PMID: 17582831 No abstract available.

5

LC/MS characterization of meningococcal depolymerized polysaccharide group C reducing endgroup and internal repeating unit.

Cai X, Lei QP, Lamb DH, Shannon A, Jacoby J, Kruk J, Kensinger RD, Ryall R, Zablackis E, Cash P. Cai X, et al. Among authors: kensinger rd. Anal Chem. 2004 Dec 15;76(24):7387-90. doi: 10.1021/ac0491760. Anal Chem. 2004. PMID: 15595884

6

Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1.

Rosa Borges A, Wieczorek L, Johnson B, Benesi AJ, Brown BK, Kensinger RD, Krebs FC, Wigdahl B, Blumenthal R, Puri A, McCutchan FE, Birx DL, Polonis VR, Schengrund CL. Rosa Borges A, et al. Among authors: kensinger rd. Virology. 2010 Dec 5;408(1):80-8. doi: 10.1016/j.virol.2010.09.004. Epub 2010 Sep 28. Virology. 2010. PMID: 20880566 Free PMC article.

7

Synthesis of novel, multivalent glycodendrimers as ligands for HIV-1 gp120.

Kensinger RD, Yowler BC, Benesi AJ, Schengrund CL. Kensinger RD, et al. Bioconjug Chem. 2004 Mar-Apr;15(2):349-58. doi: 10.1021/bc034156a. Bioconjug Chem. 2004. PMID: 15025531

8

Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection.

Kensinger RD, Catalone BJ, Krebs FC, Wigdahl B, Schengrund CL. Kensinger RD, et al. Antimicrob Agents Chemother. 2004 May;48(5):1614-23. doi: 10.1128/AAC.48.5.1614-1623.2004. Antimicrob Agents Chemother. 2004. PMID: 15105112 Free PMC article.

9

Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I.

Yowler BC, Kensinger RD, Schengrund CL. Yowler BC, et al. Among authors: kensinger rd. J Biol Chem. 2002 Sep 6;277(36):32815-9. doi: 10.1074/jbc.M205258200. Epub 2002 Jun 27. J Biol Chem. 2002. PMID: 12089155 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year